Related Experiment Video
Updated: Aug 6, 2026
08:19
Asymmetric Walkway: A Novel Behavioral Assay for Studying Asymmetric Locomotion
Published on: January 15, 2016
Asymmetric Activation
1Department of Chemical Technology Tokyo Institute of Technology Meguro-ku, Tokyo 152-8552 (Japan).
Angewandte Chemie (International Ed. in English)
|November 25, 2000
Summary
This study introduces asymmetric activation, a novel strategy using chiral activators to selectively enhance one enantiomer of a racemic catalyst. This method efficiently produces chiral products with high enantiomeric excess, offering a powerful alternative to traditional asymmetric catalysis.
Area of Science:
- Catalysis
- Organic Chemistry
- Stereochemistry
Background:
- Racemic catalysts typically yield racemic products.
- Asymmetric catalysts can be activated by chiral activators.
- Previous strategies involved selective deactivation of racemic catalysts.
Purpose of the Study:
- To present a new strategy of asymmetric activation for racemic catalysts.
- To demonstrate the selective activation of one enantiomer in a racemic catalyst.
- To achieve higher enantiomeric excess in products compared to using enantiomerically pure catalysts alone.
Main Methods:
- Selective activation of one enantiomer of a racemic catalyst using a chiral activator.
- Utilizing catalytic amounts of the chiral activator relative to the racemic catalyst.
Main Results:
- The asymmetric activation strategy yields nonracemic products with high enantiomeric excess.
- Achieved greater enantiomeric excess than with the enantiomerically pure catalyst alone.
- Demonstrated the effectiveness of activating one enantiomer of a racemic catalyst.
Conclusions:
- Asymmetric activation is a general and powerful strategy for chiral synthesis.
- Enables the use of racemic, chirally flexible, and proatropisomeric ligands without enantiomeric resolution.
- Offers an advantageous alternative to catalyst deactivation strategies.
Related Concept Videos
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
01:15Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...